The modulation of cellular pathways of programmed cell death has proved to be a promising approach in the conservation of the immune function in HIV/AIDS, as it prevents the depletion of CD4+ T lymphocytes as well as the chronic inflammatory process associated. This evidence concerns the gene CD4 and AIDS.